Ad is loading...
VADRX
Price
$80.46
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
VFINX
Price
$549.92
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
Ad is loading...

VADRX vs VFINX

Header iconVADRX vs VFINX Comparison
Open Charts VADRX vs VFINXBanner chart's image
Invesco Equally-Wtd S&P 500 R
Price$80.46
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Vanguard 500 Index Investor
Price$549.92
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
VADRX vs VFINX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VADRX vs. VFINX commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VADRX is a Buy and VFINX is a StrongSell.

FUNDAMENTALS
Fundamentals
VFINX has more cash in the bank: 1.28T vs. VADRX (7.09B). VFINX pays higher dividends than VADRX: VFINX (1.24) vs VADRX (1.12). VADRX was incepted earlier than VFINX: VADRX (17 years) vs VFINX (48 years). VADRX is a more actively managed with annual turnover of: 20.00 vs. VFINX (2.00). VFINX has a lower initial minimum investment than VADRX: VFINX (0) vs VADRX (1000). VFINX annual gain was more profitable for investors over the last year : 30.57 vs. VADRX (22.99). VFINX return over 5 years is better than : 91.24 vs. VADRX (32.57).
VADRXVFINXVADRX / VFINX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence17 years48 years-
Gain YTD17.54625.01170%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets7.09B1.28T1%
Annual Yield % from dividends1.121.2490%
Returns for 1 year22.9930.5775%
Returns for 3 years-1.3327.07-5%
Returns for 5 years32.5791.2436%
Returns for 10 years74.74189.0240%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ITOS8.130.28
+3.57%
iTeos Therapeutics
CNC60.351.25
+2.12%
Centene Corp
SKY100.081.94
+1.98%
Champion Homes Inc
CNNE20.770.23
+1.12%
Cannae Holdings
CLDI2.15-0.14
-6.11%
Calidi Biotherapeutics